Infographic: A History of Approved Therapeutic Antibodies

Which are the EMA-approved therapeutic antibodies? How about their targets and indications? The number is growing year after year — here is a timeline.

As medicine progresses into a new era of personalized therapy, therapeutic antibodies are leading the charge and have grown into a billion-euro industry. Antibodies present an attractive option for a wide variety of common diseases because of their specificity and flexibility. Major blockbusters like Humira, Remicade, MabThera, Avastin and Herceptin are therapeutic antibodies, which represent today the fastest growing group of biotechnology-derived molecules in clinical trials.

With the recent advancements in antibody engineering, we can expect to see an improvement of their half-lives, effector functions or incorporation into antibody-drug conjugates. Since the first antibody hits the market in 1986, there are currently 50 therapeutic antibodies with market approval from the EMA and thousands more in clinical trials. Here is a timeline of those approved so far! Click on this link to see the full infographic — we’d like to thank Arnaud Schlupp for the great design and implementation!

 Abs VF

Support good journalism, subscribe to Labiotech Insider

Labiotech Insider

If you liked this post and want to read more good journalism, support us by joining Labiotech Insider. Our Insider membership gives you access to exclusive content and other advantages.

We use cookies to give you the best experience. If you click on accept, we also use tracking cookies for analytics and advertising purposes. Check our privacy policy for more details. By accepting, you support our independent media and its’ freely accessible content. You may withdraw your consent at any time.